Theodore Leng, MD, FACS

In this Healio Video Perspective, Theodore Leng, MD, FACS, discusses the real-world use of faricimab for neovascular age-related macular degeneration.

Faricimab is the first and only dual-pathway inhibitor approved for use in ophthalmology; specifically, it is indicated for the treatment of wet age-related macular degeneration and diabetic macular edema.

SEATTLE — In this Healio Video Perspective from the ASRS annual meeting, Theodore Leng, MD, FACS, discusses results of the FARETINA-AMD study investigating faricimab for wet age-related macular degeneration.

The IRIS Registry, managed and curated by Verana Health’s VeraQ population health data engine, offers researchers and clinicians the opportunity to gather insights on real-world practice patterns, clinical outcomes and more.

My colleagues and I, seeking to better assess the relationship between dry age-related macular degeneration and geographic atrophy, turned to the American Academy of Ophthalmology IRIS Registry.

Some data points housed in electronic health record systems are more suitable for large-scale evaluation than others.

A handful of studies at the Association for Research in Vision and Ophthalmology 2022 annual meeting demonstrated the power of the American Academy of Ophthalmology IRIS Registry.

In 2021, we shared data on real-world quantifiable and qualifiable geographic atrophy patient patterns.

Retina specialists have a series of ancillary testing modalities at their disposal.

Research on minimally invasive glaucoma surgery continues to guide treatments and understandings of outcomes and has been instrumental in revolutionizing the field of glaucoma.